Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianjun Gao

Showing results (21-30 of 322) with videos related to

Pageof 33
Sort By:
Scientific Reports|November 13, 2024
Elevated neutrophil percentage-to-albumin ratio predicts increased all-cause and cardiovascular mortality among individuals with diabetesXiaofan Li, Zhaoyan Gu, Jianjun Gao
Drug Discoveries & Therapeutics|January 14, 2024
Development of amyloid beta-directed antibodies against Alzheimer's disease: Twists and turnsDaoran Lu, Fangzhou Dou, Jianjun Gao
Intractable & Rare Diseases Research|October 25, 2014
Research progress on flavonoids isolated from traditional Chinese medicine in treatment of Alzheimer's diseaseJianjun Gao, Yoshinori Inagaki, Yang Liu
Bioscience Trends|July 23, 2019
Overshadowed prospect of programmed cell death protein-1 (PD-1) inhibitor as monotherapy for patients with advanced hepatocellular carcinomaXu Yao, Lei Wang, Jianjun Gao
Drug Discoveries & Therapeutics|July 13, 2025
Telisotuzumab vedotin: The first-in-class c-Met-targeted antibody-drug conjugate granted FDA accelerated approval for treatment of non-squamous non-small cell lung cancer (NSCLC)Chenru Zhao, Daoran Lu, Jianjun Gao
Drug Discoveries & Therapeutics|March 10, 2020
Discovering drugs to treat coronavirus disease 2019 (COVID-19)Liying Dong, Shasha Hu, Jianjun Gao
Drug Discoveries & Therapeutics|April 13, 2025
Fitusiran: The first approved siRNA therapy for hemophilia via reducing plasma antithrombin levelsDaoran Lu, Fangzhou Dou, Jianjun Gao
Drug Discoveries & Therapeutics|March 11, 2021
Novel anticancer drugs approved in 2020Jing Li, Ruquan Wang, Jianjun Gao
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2005
Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stressJianjun Gao, Xiaoping Liu, Basil Rigas
Intractable & Rare Diseases Research|June 9, 2025
Vimseltinib: A novel colony stimulating factor 1 receptor (CSF1R) inhibitor approved for treatment of tenosynovial giant cell tumors (TGCTs)Fangzhou Dou, Daoran Lu, Jianjun Gao
Pageof 33

Showing results (21-30 of 322) with videos related to

Sort By:
Pageof 33
Scientific Reports|November 13, 2024
Elevated neutrophil percentage-to-albumin ratio predicts increased all-cause and cardiovascular mortality among individuals with diabetesXiaofan Li, Zhaoyan Gu, Jianjun Gao
Drug Discoveries & Therapeutics|January 14, 2024
Development of amyloid beta-directed antibodies against Alzheimer's disease: Twists and turnsDaoran Lu, Fangzhou Dou, Jianjun Gao
Intractable & Rare Diseases Research|October 25, 2014
Research progress on flavonoids isolated from traditional Chinese medicine in treatment of Alzheimer's diseaseJianjun Gao, Yoshinori Inagaki, Yang Liu
Bioscience Trends|July 23, 2019
Overshadowed prospect of programmed cell death protein-1 (PD-1) inhibitor as monotherapy for patients with advanced hepatocellular carcinomaXu Yao, Lei Wang, Jianjun Gao
Drug Discoveries & Therapeutics|July 13, 2025
Telisotuzumab vedotin: The first-in-class c-Met-targeted antibody-drug conjugate granted FDA accelerated approval for treatment of non-squamous non-small cell lung cancer (NSCLC)Chenru Zhao, Daoran Lu, Jianjun Gao
Drug Discoveries & Therapeutics|March 10, 2020
Discovering drugs to treat coronavirus disease 2019 (COVID-19)Liying Dong, Shasha Hu, Jianjun Gao
Drug Discoveries & Therapeutics|April 13, 2025
Fitusiran: The first approved siRNA therapy for hemophilia via reducing plasma antithrombin levelsDaoran Lu, Fangzhou Dou, Jianjun Gao
Drug Discoveries & Therapeutics|March 11, 2021
Novel anticancer drugs approved in 2020Jing Li, Ruquan Wang, Jianjun Gao
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2005
Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stressJianjun Gao, Xiaoping Liu, Basil Rigas
Intractable & Rare Diseases Research|June 9, 2025
Vimseltinib: A novel colony stimulating factor 1 receptor (CSF1R) inhibitor approved for treatment of tenosynovial giant cell tumors (TGCTs)Fangzhou Dou, Daoran Lu, Jianjun Gao
Pageof 33